Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-037492
Filing Date
2016-08-15
Accepted
2016-08-15 16:55:16
Documents
68
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rpbif20160630_10q.htm 10-Q 1212061
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10892
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10814
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5967
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5697
  Complete submission text file 0001437749-16-037492.txt   5454521

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS rpbif-20160630.xml EX-101.INS 1014205
7 EXHIBIT 101.SCH rpbif-20160630.xsd EX-101.SCH 56702
8 EXHIBIT 101.CAL rpbif-20160630_cal.xml EX-101.CAL 40059
9 EXHIBIT 101.DEF rpbif-20160630_def.xml EX-101.DEF 421247
10 EXHIBIT 101.LAB rpbif-20160630_lab.xml EX-101.LAB 336946
11 EXHIBIT 101.PRE rpbif-20160630_pre.xml EX-101.PRE 434032
Mailing Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2
Business Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2 604-456-6010
RESPONSE BIOMEDICAL CORP (Filer) CIK: 0000806888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50571 | Film No.: 161833568
SIC: 8734 Services-Testing Laboratories